Hypersensitivity to the levocetirizine hydrochloride, to cetirizine, to hydroxyzine, to any other piperazine derivatives or to any of the other excipients.
Patients with end stage renal disease with estimate Glomerular Filtration Rate (eGFR) below 15 ml/min (requiring dialysis treatment).